| Date | Time | Source | Headline | Symbol | Company |
| 10/20/2009 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Fiscal Second Quarter 2010 Earnings Per Share of $0.61, Including a Net $0.24 Per Share Cha... | NYSE:FRX | Forest Road Acquisition Corp |
| 10/17/2009 | 5:00PM | Business Wire | Forest Laboratories & Cypress Bioscience Announce Study Shows Patients Treated with Savella Experience Improvements in Pain &... | NYSE:FRX | Forest Road Acquisition Corp |
| 10/14/2009 | 5:44AM | Marketwired | TheFortuneFinacial.com Progressive Review on BDN, EXH, GME, CL, FRX and LMT | NYSE:FRX | Forest Road Acquisition Corp |
| 10/05/2009 | 8:00AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
| 10/05/2009 | 6:16AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of FRX, AVT, LUK, MWV, DPS and PL | NYSE:FRX | Forest Road Acquisition Corp |
| 09/22/2009 | 6:24AM | Marketwired | BenchmarkJournal.com Free Analyst Review for ARE, CL, EJ, FRX, AVB and COT | NYSE:FRX | Forest Road Acquisition Corp |
| 09/17/2009 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 09/12/2009 | 2:35PM | Business Wire | Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community... | NYSE:FRX | Forest Road Acquisition Corp |
| 09/09/2009 | 7:17AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on MWV, DFS, WDR, DHR, FRX and WTSLA | NYSE:FRX | Forest Road Acquisition Corp |
| 08/27/2009 | 6:45PM | Business Wire | Forest Laboratories, Inc. & Nycomed Announce a Conference Call to Review Publication of Daxas® Phase III Clinical Trial Results | NYSE:FRX | Forest Road Acquisition Corp |
| 08/27/2009 | 6:35PM | Business Wire | Four Studies Published in The Lancet Show Roflumilast (Daxas®), a New Oral Approach to COPD, Improves Lung Function & Reduce... | NYSE:FRX | Forest Road Acquisition Corp |
| 08/27/2009 | 6:31PM | PR Newswire (US) | Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce | NYSE:FRX | |
| 08/26/2009 | 6:22AM | Marketwired | RothmanResearch.com Stock Review for UIS, BEN, AVT, FRX, BKD and LIZ | NYSE:FRX | Forest Road Acquisition Corp |
| 08/19/2009 | 9:50AM | Dow Jones News | 2nd UPDATE: Glenmark, Forest Say Their Drug Failed In Trials | NYSE:FRX | Forest Laboratories Inc. |
| 08/19/2009 | 3:53AM | Dow Jones News | UPDATE: Glenmark, Forest Say Oglemilast Failed In Key Study | NYSE:FRX | Forest Laboratories Inc. |
| 08/18/2009 | 11:00PM | Business Wire | Forest Announces Phase IIb Study Results For Oglemilast in Chronic Obstructive Pulmonary Disease | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2009 | 6:42AM | Marketwired | TheFortuneFinancial.com Free Market Research on APH, HOG, FRX, DOX, LIZ and ITT | NYSE:FRX | Forest Road Acquisition Corp |
| 08/12/2009 | 4:32AM | Dow Jones News | AstraZeneca, Forest Labs Ink Ceftaroline Deal | NYSE:FRX | Forest Laboratories Inc. |
| 08/12/2009 | 4:00AM | Business Wire | Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:59AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:58AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:58AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:57AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:57AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/11/2009 | 11:56AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/10/2009 | 2:31PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
| 08/10/2009 | 7:00AM | Business Wire | Nycomed and Forest Laboratories to Collaborate on Daxas® (roflumilast) for COPD | NYSE:FRX | Forest Road Acquisition Corp |
| 08/10/2009 | 7:00AM | PR Newswire (US) | Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD | NYSE:FRX | |
| 07/21/2009 | 5:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 07/21/2009 | 9:08AM | Dow Jones News | Forest Labs 1Q Net Up 8.2% As Namenda Sales Jump | NYSE:FRX | Forest Laboratories Inc. |